We found 208 records for "Drug safety / pharmacovigilance"

Articles

Early access initiatives – one year on

28th April 2015

 Early access initiatives – one year onArticles

Both the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) and the European Medicines Agency (EMA) launched new initiatives aimed at achieving earlier access to promising new medicines a year...

Read more

Can the rise in drug-drug interactions be halted, or is it an inevitable side effect?

5th March 2015

 Can the rise in drug-drug interactions be halted, or is it an inevitable side effect?Articles

The trend towards patients taking several medications at the same time is increasing, especially with the ageing population, giving rise to a corresponding rise in the possibility of adverse reactions....

Read more

Applying marketing thinking to the clinical trial process

4th March 2015

 Applying marketing thinking to the clinical trial processArticles

In order to attract and retain patients for a clinical trial, clinical teams should start early on planning and implementing their marketing strategies. Ken Wallace suggests the patient recruitment questions...

Read more

Does real world evidence matter in Health Technology Assessments?

27th January 2015

 Does real world evidence matter in Health Technology Assessments?Articles

Health Technology Assessment (HTA) agencies usually rely on randomised controlled trials for clinical data when evaluating drugs, but these do not always tell the entire story. Both biopharmaceutical companies and...

Read more

News

Future of AZ’s psoriasis drug in doubt after Amgen withdrawal

27th May 2015

 Future of AZ’s psoriasis drug in doubt after Amgen withdrawalNews

AstraZeneca (AZ) will be forced to make a difficult decision on its psoriasis drug brodalumab after Amgen pulled out of the development partnership.Brodalumab had been tipped to reach peak sales...

Read more

FDA warns on AZ, Lilly and J&J diabetes drug safety

18th May 2015

 FDA warns on AZ, Lilly and J&J diabetes drug safetyNews

The FDA has warned that patients taking a newer class of diabetes drugs may cause dangerously high level of blood acids, which could require hospitalisation.The sodium-glucose cotransporter-2 (SGLT2) inhibitor drugs...

Read more

Takeda settles Actos damages case for $2.7bn

29th April 2015

 Takeda settles Actos damages case for $2.7bnNews

Takeda has agreed to pay an eye-watering $2.7 billion to settle claims that its diabetes drug Actos caused bladder cancer, in one of the largest cases of its kind in...

Read more

Delay is bad news for Lilly’s insulin contender

24th February 2015

 Delay is bad news for Lilly’s insulin contenderNews

Lilly says its new long-acting insulin will be delayed by more than a year because of doubts about liver side effects.The company had planned to file its new basal insulin...

Read more

White Papers

Diabetes in France

23rd July 2014

 Diabetes in FranceWhite Papers

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,...

Read more

Diabetes in Germany

16th July 2014

 Diabetes in GermanyWhite Papers

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,...

Read more

Diabetes in the UK

9th July 2014

 Diabetes in the UKWhite Papers

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,...

Read more

Understanding the psychological blocks in medicine-taking: how pharma can help

17th June 2014

 Understanding the psychological blocks in medicine-taking: how pharma can helpWhite Papers

Medicines adherence remains a massive problem for healthcare systems, the pharmaceutical industry and patients, leading to increased disease burden and personal risks. In this new white paper, Hannah Gagen looks...

Read more

Audio & Video

Full round table: Oncology shaping the future of personalised healthcare

  Watch the full round table video debate on 'oncology shaping the future of personalised healthcare', to see what our expert panel, with representation from pharma, diagnostics, physicians and patients, think...

Read more

Part four: Oncology shaping the future of personalised healthcare

  In the final section of our video round table on personalised healthcare in oncology, the expert panel reviews where this space is heading, how lessons learned can apply beyond cancer...

Read more

Events

Beating Malaria 2015

29th June 2015

Beating Malaria 2015

With plenty of opportunity for networking and debate, this informal, multi-disciplinary international meeting will bring you up to date with current research and thinking regarding Malaria infection, treatment...

Read more

Lyophilisation Europe

29th June 2015 - 30th June 2015

Lyophilisation Europe

SMi Group are thrilled to present the 3rd annual European event: Lyophilisation Europe, taking place on 29th & 30th June 2015, in Central London. Spurred by the growth of the new...

Read more

Joint EMA/DIA Information Day on Risk Management Planning

30th June 2015

Joint EMA/DIA Information Day on Risk Management Planning

The Pharmacovigilance Risk Assessment Committee (PRAC) has been operational since the implementation of the Pharmacovigilance Legislation in July 2012. Pharmacovigilance guidelines are in place specific for the area of risk...

Read more

ON Helix

14th July 2015

ON Helix

ON Helix is our translational research conference for the life science sector. ON Helix is a one day event aimed at informing delegates of how to turn early stage inventions and...

Read more

Press Releases

UK’s Department of Health deploys information campaign to ensure continued vigilance over Ebola

27th March 2015

UK’s Department of Health deploys information campaign to ensure continued vigilance over Ebola

The threat of Ebola being transmitted within the UK may be low but frontline health workers must remain vigilant nevertheless. This is the message being communicated by the Department of...

Read more

New Schoonveld book is now available!

10th December 2014

New Schoonveld book is now available!

It's here!   The eagerly awaited new editon of THE PRICE OF GLOBAL HEALTH  is now available.   Written by global drug pricing expert Ed Schoonveld, The Price of Global Health (second edition) is...

Read more

Ashfield Commercial & Medical Services redefines healthcare outsourcing to meet pharma's challenges

5th February 2014

Ashfield Commercial & Medical Services redefines healthcare outsourcing to meet pharma's challenges

  Ashfield Commercial & Medical Services   redefines healthcare outsourcing to meet pharma’s challenges   03 February 2014: UDG Healthcare plc (formerly United Drug plc), a leading international provider of services to healthcare manufacturers...

Read more

Datatrial Presented with Prestigious Award at SCDM Annual Conference

2nd October 2013

Datatrial Presented with Prestigious Award at SCDM Annual Conference

Efficient CDM Process Earns Boutique Data Management Company a Data Driven Innovation Award Chicago, October 2, 2013—At the Society for Clinical Data Management (SCDM) annual meeting, Datatrial was among three companies...

Read more